Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Fzd2 is important for skin and hair development through various signaling ways.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Two new compounds were found to effectively reduce hair growth in mice.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Mutations in the desmoplakin gene can cause hair problems and deadly heart disease.

Simvastatin helps hair follicle stem cells turn into skin cells.

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

HIF-1α stimulators, like deferiprone, work as well as popular hair loss treatments, minoxidil and caffeine, in promoting hair growth.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Finasteride helped treat a 28-year-old's facial skin condition.

ALRN-6924 may prevent hair loss caused by chemotherapy.

A boy with Oculodentodigital syndrome had a unique GJA1 gene mutation causing his symptoms.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.